Friday, November 22, 2024

Massachusetts Rec Cannabis Sales Have Now Topped $7Million In 3 Weeks

The Daily Hampshire Gazette reports:

A total of $2,218,208.47 in gross sales was made from legal recreational marijuana and marijuana products last week in Massachusetts.

The week three total was slightly more than the week one total of $2,217,621 in gross sales, but less than week two’s total of $2,586,863, according to data released by the Cannabis Control Commission.

Combined with the first two weeks of sales, over $7 million of legal recreational marijuana and marijuana products have been sold.

All of these sales took place in only two locations: New England Treatment Access in Northampton and Cultivate in Leicester. Both dispensaries were first opened, and also continue to operate, as medical marijuana dispensaries.

The CCC has not released sales data for individual store locations. However, lines outside the building continue to be seen at NETA at all hours of operation.

Alternative Therapies Group, a Salem medical marijuana dispensary, was recently cleared to begin recreational marijuana sales by the CCC, and it is set to start them Saturday. This will make it the third location in the Bay State, and the third east of the Mississippi to sell legal recreational marijuana.

ATG was the first medical marijuana dispensary to begin serving patients in Massachusetts.

This article originally appeared on Green Market Report.

MUST READ

A Glass Of Water Should Only Sit Out For This Long

Everything has a shelf life, but what about the basic drink? A glass of water should only sit out for this long explained.

MORE BY THIS AUTHOR

There Are More Cannabis Workers In The US Than Librarians Or Pilots

As institutional investors warm up to the cannabis industry, high-profile mergers and acquisitions are beginning to shape the multi-state cannabis market outlook.

Don't Miss Your Weekly Dose of The Fresh Toast.

Stay informed with exclusive news briefs delivered directly to your inbox every Friday.

We respect your privacy. Unsubscribe anytime.